REGULATORY INTELLIGENCE·Recall
Novocol Pharmaceutical Recalls Carbocaine 3% Mepivacaine HCl Due to Defective Cartridges
Novocol Pharmaceutical of Canada, Inc. initiated a Class II recall of Carbocaine 3% (mepivacaine hydrochloride) due to cracked cartridges. This voluntary action impacts U.S. nationwide supply, posing risks to patient safety and supply chain stability for dental practitioners. Procurement and regulatory teams must assess immediate inventory and long-term sourcing strategies.
90-Day Activity